In this study, utilizing an approach similar to that used in our prior work on giant axonal neuropathy and CLN7 gene therapies, we evaluated the efficacy and safety of AP4M1 gene transfer in vitro in fibroblasts from patients with SPG50 and in vivo in Ap4m1-KO mice. This evidence concerns the gene AP4M1 and giant axonal neuropathy.